Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
93619501000001110 | Pembrolizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
93619601000001114 | Pembrolizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Pembrolizumab | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier | ||
Pembrolizumab | Is a | Product containing monoclonal antibody | false | Inferred relationship | Existential restriction modifier | ||
Pembrolizumab | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Pembrolizumab 50mg powder for solution for infusion vials | Is a | False | Pembrolizumab | Inferred relationship | Existential restriction modifier | |
Pembrolizumab 100mg/4ml solution for infusion vials | Is a | False | Pembrolizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets